New Zealand updates TB (tuberculosis) screening and care policy:
This article was originally published in Clinica
New Zealand's ministry of health has updated its guidelines on the screening and treatment of tuberculosis. They reflect, says the ministry, the latest technological developments in controlling the disease. The government is considering tightening the screening of TB among inbound travellers and migrants.
You may also be interested in...
Moderate growth at Bristol-Myers Squibb and Amgen moved the two companies into the top 10 pharma ranks, based on the most recent Scrip 100 rankings, while declining growth at Gilead and Teva moved those drug makers out.
Momenta Pharmaceuticals has agreed to pay $35.0m to settle claims that it manipulated generic approval processes in the US to shut competitor Amphastar out of the US enoxaparin market.